Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02539459
Title Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Acronym SAGE
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.